Isoprenoids as mediators of the biological effects of statins
about
Statins for the treatment of dementiaStatins for the treatment of dementiaStatins for the treatment of Alzheimer's disease and dementiaStatins for the prevention of dementiaThe muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicityThe bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood gd T cells in response to aminobisphosphonates is inhibited by statinsTiming of Administration: For Commonly-Prescribed Medicines in AustraliaEmerging therapies for the prevention of acute respiratory distress syndromeProtein prenylation and synaptic plasticity: implications for Alzheimer's diseaseEvaluation of the effect of genetic variation on the relationship between statins, cardiovascular disease and cancerOngoing clinical trials of the pleiotropic effects of statinsStatin therapy and autoimmune disease: from protein prenylation to immunomodulationInterplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motilityHepatic and pulmonary toxicogenomic profiles in mice intratracheally instilled with carbon black nanoparticles reveal pulmonary inflammation, acute phase response, and alterations in lipid homeostasisMevalonate cascade regulation of airway mesenchymal cell autophagy and apoptosis: a dual role for p53Brain cholesterol turnover required for geranylgeraniol production and learning in mice.Atorvastatin induces apoptosis by a caspase-9-dependent pathway: an in vitro study on activated rat hepatic stellate cells.Atorvastatin reduces plasma levels of chemokine (CXCL10) in patients with Crohn's disease.Tumour-specific HMG-CoAR is an independent predictor of recurrence free survival in epithelial ovarian cancerTherapeutic potential of statins in multiple sclerosis: immune modulation, neuroprotection and neurorepair.Simvastatin enhances hippocampal long-term potentiation in C57BL/6 mice.Influence of co-existing atrial fibrillation on the efficacy of atorvastatin treatment in patients with dilated cardiomyopathy: a pilot study.Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer.Effects of lovastatin on breast cancer cells: a proteo-metabonomic study.Statin therapy is associated with improved survival in patients with non-serous-papillary epithelial ovarian cancer: a retrospective cohort analysis.Isoprenoid quantitation in human brain tissue: a validated HPLC-fluorescence detection method for endogenous farnesyl- (FPP) and geranylgeranylpyrophosphate (GGPP).Simvastatin treatment enhances NMDAR-mediated synaptic transmission by upregulating the surface distribution of the GluN2B subunit.Statins and myocardial remodelling: cell and molecular pathways.Cochrane review on 'Statins for the treatment of dementia'.The effect of rosuvastatin in a murine model of influenza A infection.The effect of statin on epithelial-mesenchymal transition in peritoneal mesothelial cells.Distribution of endogenous farnesyl pyrophosphate and four species of lysophosphatidic acid in rodent brain.A genetic and pharmacological analysis of isoprenoid pathway by LC-MS/MS in fission yeastStatins: cardiovascular risk reduction in percutaneous coronary intervention-basic and clinical evidence of hyperacute use of statins.Role of cholesterol in the development and progression of breast cancerStatins decrease dendritic arborization in rat sympathetic neurons by blocking RhoA activation.Stimulation of osteoclast formation by RANKL requires interferon regulatory factor-4 and is inhibited by simvastatin in a mouse model of bone loss.Roles of cholesterol and lipids in the etiopathogenesis of Alzheimer's disease.Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifenSimvastatin inhibits TGFβ1-induced fibronectin in human airway fibroblasts
P2860
Q24194901-F3A7526F-A713-4239-9759-8C389F3D9A57Q24236484-DB70EB30-BC19-4D58-99BA-45FFBC46A9E1Q24240305-55496002-6EAE-43BD-8AE1-50F39B0DACA3Q24241335-3B285121-C564-415F-B097-D6E591B2CAAAQ24681859-75C3DC91-4F53-43EA-A45B-977B8E33F740Q24684244-7AE1927E-056B-4246-BE33-BEB56D06A6E4Q26752357-1F85BAC8-4901-4DB2-8CD9-F3214B7F2A0FQ26822605-E8C7F498-DB80-40A3-896E-45B95F2E434DQ26858942-FB536F3B-0C51-4AA0-9C14-9B15F73670D8Q27026358-822B5B34-5F00-4394-A6EC-9614B3C28688Q28219321-A993AD95-C3C6-48AC-AD2F-3B093DCA65F0Q28236647-184821E1-8C0C-4792-9AFE-C81F6CD2F589Q28304661-7C98F709-3626-4763-9546-B26DA5A7E788Q28384557-26B135FA-BE1C-4417-AC7F-05D9FF35AC44Q28477034-B6345B49-BC71-480C-81A0-0B56396958A4Q30477204-5A714940-A8A1-43D3-953F-1944B2C120BAQ33323649-27458D99-147A-4B93-8FF1-7DAD7A6C19EEQ33440583-41574931-569D-4470-A89C-3E782977A220Q33548538-88C17034-B16C-4A5D-AB43-6FAB6883F127Q33610240-DF0747A4-1B87-4BC1-AF54-3CAB77795001Q33665597-34FF38F9-33C3-4C43-B497-B98C566B59BDQ33711829-60E56B06-14A9-454C-BAB3-5BBBF9E397B3Q33864834-B93FDA05-63EB-478A-85B6-822044106CFEQ33889477-DFEFC484-3C47-4928-81B0-4E1DBE62BC02Q34041112-A64B2CDF-94FF-4503-89F8-828365818A5FQ34071260-341D7CF4-637F-4C7D-B853-7906CDFA6541Q34081527-DAFC6C03-F61C-42D5-A8F0-895D2AD00CC8Q34196628-F3F36406-1DAC-48EF-90B3-150BE9B88953Q34219516-64503872-73D6-4B66-8A2C-41F71986B2CFQ34247532-BE052397-2D36-45E5-963A-CA12A621DFB5Q34282610-89790318-4C86-4250-98FF-0B9D804F2633Q34378141-B49CFB97-2E43-48E2-8DEB-E39304DB2495Q34473860-8FA033E4-4E7D-47BC-B7D3-CF79ED0873D9Q34729472-BB146F10-9595-463C-858E-7F6F28C4DB65Q34755686-543C5C77-622B-413B-8FEE-A9997DC69F3FQ34778613-16695B92-DCBE-41F0-8367-C9C0C67CA77CQ34988281-391E5110-2216-4A04-97B6-5CA69A6BAC21Q35016920-5F0CC551-56C6-4BA0-8D96-4A82959C9071Q35029556-1CA067B7-63C7-44C6-A2C5-79D7B8E304D0Q35213717-7C1276FE-883B-4D4F-BD06-F08AC426F4B8
P2860
Isoprenoids as mediators of the biological effects of statins
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Isoprenoids as mediators of the biological effects of statins
@ast
Isoprenoids as mediators of the biological effects of statins
@en
Isoprenoids as mediators of the biological effects of statins
@nl
type
label
Isoprenoids as mediators of the biological effects of statins
@ast
Isoprenoids as mediators of the biological effects of statins
@en
Isoprenoids as mediators of the biological effects of statins
@nl
prefLabel
Isoprenoids as mediators of the biological effects of statins
@ast
Isoprenoids as mediators of the biological effects of statins
@en
Isoprenoids as mediators of the biological effects of statins
@nl
P2860
P356
P1476
Isoprenoids as mediators of the biological effects of statins
@en
P2093
James K Liao
P2860
P304
P356
10.1172/JCI0216421
P407
P577
2002-08-01T00:00:00Z